These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28064317)

  • 1. [B7-H4-mediated immunoresistance is supressed by PI3K/Akt/mTOR pathway inhibitors].
    Zeng S; Song H; Chen Y; Xie W; Zhang L
    Mol Biol (Mosk); 2016; 50(6):1007-1013. PubMed ID: 28064317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of PI3K/AKT signaling pathway promotes the nuclear translocation of B7-H4].
    Song H; Xie W; Lian Q; Chen M; Xu R; Zeng S; Zhang L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Nov; 30(11):1121-4. PubMed ID: 25374071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-H4 facilitates proliferation and metastasis of colorectal carcinoma cell through PI3K/Akt/mTOR signaling pathway.
    Li C; Zhan Y; Ma X; Fang H; Gai X
    Clin Exp Med; 2020 Feb; 20(1):79-86. PubMed ID: 31664539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function.
    Crane C; Panner A; Pieper RO; Arbiser J; Parsa AT
    J Immunother; 2009; 32(6):585-92. PubMed ID: 19483651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
    Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
    Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
    Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
    Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Phosphatidylinositol-3-Kinase-Akt-mTOR Activation by Semliki Forest and Chikungunya Viruses Is Dependent on nsP3 and Connected to Replication Complex Internalization.
    Thaa B; Biasiotto R; Eng K; Neuvonen M; Götte B; Rheinemann L; Mutso M; Utt A; Varghese F; Balistreri G; Merits A; Ahola T; McInerney GM
    J Virol; 2015 Nov; 89(22):11420-37. PubMed ID: 26339054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the PI3K/mTOR signaling pathway in Staphylococcus epidermidis small colony variants intracellular survival.
    Magryś A; Bogut A; Kiełbus M; Olender A
    Immunol Invest; 2018 Apr; 47(3):251-263. PubMed ID: 29336620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
    Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc enhances intestinal epithelial barrier function through the PI3K/AKT/mTOR signaling pathway in Caco-2 cells.
    Shao Y; Wolf PG; Guo S; Guo Y; Gaskins HR; Zhang B
    J Nutr Biochem; 2017 May; 43():18-26. PubMed ID: 28193579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway.
    Bussolati B; Assenzio B; Deregibus MC; Camussi G
    J Mol Med (Berl); 2006 Oct; 84(10):852-63. PubMed ID: 16924472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
    Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT
    Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
    Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis.
    Faghiri Z; Bazan NG
    Exp Eye Res; 2010 Jun; 90(6):718-25. PubMed ID: 20230819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway.
    Lee KW; Yook JY; Son MY; Kim MJ; Koo DB; Han YM; Cho YS
    Stem Cells Dev; 2010 Apr; 19(4):557-68. PubMed ID: 19642865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.
    Sun SY; Rosenberg LM; Wang X; Zhou Z; Yue P; Fu H; Khuri FR
    Cancer Res; 2005 Aug; 65(16):7052-8. PubMed ID: 16103051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TOR kinase and Ran are downstream from PI3K/Akt in H2O2-induced mitosis.
    Radisavljevic ZM; González-Flecha B
    J Cell Biochem; 2004 Apr; 91(6):1293-300. PubMed ID: 15048882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK1/2 is involved in luteal cell autophagy regulation during corpus luteum regression via an mTOR-independent pathway.
    Choi J; Jo M; Lee E; Choi D
    Mol Hum Reprod; 2014 Oct; 20(10):972-80. PubMed ID: 25107837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
    Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
    Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.